Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Routine noninvasive prenatal screening for fetal Rh D in maternal plasma-A 2-year experience from a single center in Belgium.

Transfusion - 1 May 2022

Blomme Siska, Nollet Friedel, Rosseel Wesley, Bogaard Natalie, Devos Helena, Emmerechts Jan, Cauwelier Barbara

Abstract excerpt

BACKGROUND: Hemolytic disease of the fetus and newborn (HDFN) due to rhesus D (RhD) immunization is a potentially life-threatening situation for which use of Rh Immunoglobulin (RhIg) has decreased risk drastically. Determination of fetal RHD on maternal plasma can be used to restrict prenatal RhIg administration to women carrying an RhD-positive child, avoiding unnecessary administration of blood-derived...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Belgium
Share to Erythroblastosis, Fetal

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Pregnancy

Share to Prenatal Diagnosis

Share to Rh-Hr Blood-Group System

Share to Rho(D) Immune Globulin

Source

Identifiers

PMID: 35352833
DOI: 10.1111/trf.16868

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Routine noninvasive prenatal screening for fetal Rh D in maternal plasma-A 2-year experience from a single center in Belgium.PMID 35352833Read ↗

Investigation of discrepancies obtained during 15 years of non-invasive fetal RHD genotyping in apparent serologic RhD-negative pregnant women.Semantic proximity Read ↗

Routine fetal RHD genotyping with maternal plasma: a four-year experience in Belgium.Semantic proximity Read ↗

Single-exon fetal RHD genotyping: a 31-month follow up in the obstetric population of Western Sweden.Semantic proximity Read ↗

Evaluation of an automated platform for non-invasive single-exon fetal RHD genotyping early in pregnancy.Semantic proximity Read ↗

Non-invasive foetal RhD genotyping: A strategy for rationalizing anti-D immunoglobulin prophylaxis in RhD-negative pregnant women at the Hospital Italiano de Buenos Aires.Semantic proximity Read ↗

Non-Invasive Prenatal Fetal Blood Group Genotype and Its Application in the Management of Hemolytic Disease of Fetus and Newborn: Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time.Semantic proximity Read ↗

Prenatal screening service for fetal RHD genotyping to guide prophylaxis: the two-year experience of the Friuli Venezia Giulia region in Italy.Semantic proximity Read ↗

Non-invasive fetal RHD genotyping in the first trimester of pregnancy.Semantic proximity Read ↗

Terminating Routine Cord Blood RhD Typing of the Newborns to Guide Postnatal Anti-D Immunoglobulin Prophylaxis Based on the Results of Fetal RHD Genotyping.Semantic proximity Read ↗

Routine noninvasive prenatal screening for fetal <i>RHD</i> in plasma of RhD‐negative pregnant women—2 years of screening experience from DenmarkSemantic proximity Read ↗

RHD genotyping from maternal plasma: guidelines and technical challenges.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.